PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,028 | -42.0% | 33,519 | -24.2% | 0.00% | -50.0% |
| Q2 2023 | $1,773 | +2.6% | 44,239 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $1,728 | -13.5% | 42,348 | -18.1% | 0.00% | -33.3% |
| Q4 2022 | $1,997 | -99.9% | 51,724 | +0.2% | 0.00% | -25.0% |
| Q3 2022 | $2,747,000 | -47.0% | 51,643 | -41.9% | 0.00% | -42.9% |
| Q2 2022 | $5,182,000 | -58.4% | 88,884 | -45.6% | 0.01% | -46.2% |
| Q1 2022 | $12,459,000 | +459.0% | 163,242 | +340.6% | 0.01% | +550.0% |
| Q4 2021 | $2,229,000 | -23.7% | 37,050 | -29.0% | 0.00% | -33.3% |
| Q3 2021 | $2,920,000 | -12.0% | 52,147 | -4.7% | 0.00% | 0.0% |
| Q2 2021 | $3,319,000 | -21.8% | 54,700 | -9.7% | 0.00% | -40.0% |
| Q1 2021 | $4,245,000 | +44.0% | 60,560 | +23.0% | 0.01% | +66.7% |
| Q4 2020 | $2,947,000 | -24.2% | 49,248 | -23.9% | 0.00% | -40.0% |
| Q3 2020 | $3,889,000 | +15.7% | 64,679 | +1.0% | 0.01% | +25.0% |
| Q2 2020 | $3,360,000 | +55.4% | 64,045 | -0.7% | 0.00% | +33.3% |
| Q1 2020 | $2,162,000 | -25.9% | 64,481 | +0.2% | 0.00% | 0.0% |
| Q4 2019 | $2,916,000 | +13.8% | 64,381 | -4.4% | 0.00% | 0.0% |
| Q3 2019 | $2,563,000 | -71.3% | 67,331 | -67.2% | 0.00% | -72.7% |
| Q2 2019 | $8,927,000 | +18.5% | 205,261 | +3.7% | 0.01% | +10.0% |
| Q1 2019 | $7,532,000 | -2.3% | 197,885 | +10.5% | 0.01% | -9.1% |
| Q4 2018 | $7,708,000 | -19.5% | 179,162 | -8.1% | 0.01% | 0.0% |
| Q3 2018 | $9,579,000 | +62.3% | 194,900 | +5.9% | 0.01% | +57.1% |
| Q2 2018 | $5,901,000 | -11.5% | 184,115 | -14.0% | 0.01% | -12.5% |
| Q1 2018 | $6,666,000 | -20.3% | 214,011 | +16.9% | 0.01% | -20.0% |
| Q4 2017 | $8,360,000 | +33.4% | 183,130 | +9.7% | 0.01% | +25.0% |
| Q3 2017 | $6,268,000 | -22.7% | 166,934 | -1.8% | 0.01% | -27.3% |
| Q2 2017 | $8,111,000 | +207.8% | 170,039 | +194.3% | 0.01% | +175.0% |
| Q1 2017 | $2,635,000 | +80.1% | 57,776 | +27.6% | 0.00% | +100.0% |
| Q4 2016 | $1,463,000 | -3.2% | 45,280 | +2.5% | 0.00% | 0.0% |
| Q3 2016 | $1,511,000 | +3.6% | 44,162 | +2.2% | 0.00% | 0.0% |
| Q2 2016 | $1,458,000 | -35.7% | 43,213 | +1.0% | 0.00% | -33.3% |
| Q1 2016 | $2,267,000 | -48.6% | 42,785 | -25.6% | 0.00% | -57.1% |
| Q4 2015 | $4,414,000 | +158.1% | 57,483 | +38.1% | 0.01% | +133.3% |
| Q3 2015 | $1,710,000 | -44.7% | 41,616 | -4.8% | 0.00% | -40.0% |
| Q2 2015 | $3,093,000 | +2589.6% | 43,735 | +3292.9% | 0.01% | – |
| Q1 2015 | $115,000 | -91.8% | 1,289 | -91.1% | 0.00% | -100.0% |
| Q3 2014 | $1,396,000 | +5.5% | 14,405 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,323,000 | – | 14,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |